Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Endocrine 3

Conditions

Breast Neoplasms 3092Neoplasms 2436Carcinoma, Non-Small-Cell Lung 1863Prostatic Neoplasms 1617Colorectal Neoplasms 1422Lung Neoplasms 1292Multiple Myeloma 927Neoplasm Metastasis 919Leukemia, Myeloid, Acute 874Pancreatic Neoplasms 847Ovarian Neoplasms 799Melanoma 783Carcinoma, Hepatocellular 736Stomach Neoplasms 639Brain Neoplasms 635Recurrence 633Squamous Cell Carcinoma of Head and Neck 630Head and Neck Neoplasms 609Glioblastoma 566Lymphoma 539Uterine Cervical Neoplasms 537Triple Negative Breast Neoplasms 504Precursor Cell Lymphoblastic Leukemia-Lymphoma 499Carcinoma, Renal Cell 497Hematologic Neoplasms 462Urinary Bladder Neoplasms 459Endometrial Neoplasms 459Colonic Neoplasms 441Lymphoma, Non-Hodgkin 435Sarcoma 434

Interventions

Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Adrenocortical Adenoma × 1 year × Clear all
NCT05368090 2026-05-08

Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism

Haukeland University Hospital

Phase NA Recruiting
60 enrolled
Endocrine

Cushing Syndrome, Hyperaldosteronism, Adrenocortical Adenoma

NCT07470580 2026-03-13

ADERADHTA2

University Hospital, Toulouse

Phase NA Not yet recruiting
134 enrolled
Endocrine

Hyperaldosteronism, Hypertension, Hypokalemia, Adrenocortical Adenoma

NCT07027254 2025-06-18

PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism

Seoul National University Hospital

Phase NA Recruiting
90 enrolled
Endocrine

Hyperaldosteronism, Adrenocortical Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡